Search research articles
Contact Us
Filters
Showing results (461-470 of 510) with videos related to
Page
of 51
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial
Alfredo Carrato, Anna Swieboda-Sadlej, Marzanna Staszewska-Skurczynska, et al.
Cancer
|
December 21, 2018
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
Petros Grivas, Amir Mortazavi, Joel Picus, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity
Jing Yuan, Pramod P Mehta, Min-Jean Yin, et al.
Cancer Discovery
|
July 8, 2024
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer
Anupriya Singhal, Hannah C Styers, Jonathan Rub, et al.
Cancer Cell
|
February 5, 2010
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
Alexa B Turke, Kreshnik Zejnullahu, Yi-Long Wu, et al.
Genome Research
|
March 9, 2013
Global analysis of Drosophila Cys₂-His₂ zinc finger proteins reveals a multitude of novel recognition motifs and binding determinants
Metewo Selase Enuameh, Yuna Asriyan, Adam Richards, et al.
Journal of Internal Medicine
|
December 17, 2013
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure
E T Askevold, P Aukrust, S H Nymo, et al.
Pigment Cell & Melanoma Research
|
February 6, 2014
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
Richard J Young, Kelly Waldeck, Claire Martin, et al.
The New England Journal of Medicine
|
October 29, 2010
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor
James E Butrynski, David R D'Adamo, Jason L Hornick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2022
Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer
Joshua K Sabari, Vamsidhar Velcheti, Kazuhide Shimizu, et al.
Page
of 51
Search research articles
Search
Showing results (461-470 of 510) with videos related to
Sort By:
Page
of 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial
Alfredo Carrato, Anna Swieboda-Sadlej, Marzanna Staszewska-Skurczynska, et al.
Cancer
|
December 21, 2018
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
Petros Grivas, Amir Mortazavi, Joel Picus, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity
Jing Yuan, Pramod P Mehta, Min-Jean Yin, et al.
Cancer Discovery
|
July 8, 2024
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer
Anupriya Singhal, Hannah C Styers, Jonathan Rub, et al.
Cancer Cell
|
February 5, 2010
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
Alexa B Turke, Kreshnik Zejnullahu, Yi-Long Wu, et al.
Genome Research
|
March 9, 2013
Global analysis of Drosophila Cys₂-His₂ zinc finger proteins reveals a multitude of novel recognition motifs and binding determinants
Metewo Selase Enuameh, Yuna Asriyan, Adam Richards, et al.
Journal of Internal Medicine
|
December 17, 2013
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure
E T Askevold, P Aukrust, S H Nymo, et al.
Pigment Cell & Melanoma Research
|
February 6, 2014
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
Richard J Young, Kelly Waldeck, Claire Martin, et al.
The New England Journal of Medicine
|
October 29, 2010
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor
James E Butrynski, David R D'Adamo, Jason L Hornick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2022
Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer
Joshua K Sabari, Vamsidhar Velcheti, Kazuhide Shimizu, et al.
Page
of 51